ZYUS Life Sciences to Acquire Revon Systems

The following is an excerpt from a news release issued on July 3 by ZYUS, an Innovation Place tenant located in Saskatoon.

ZYUS to leverage Revon’s proprietary technology platform in clinical studies and trials of innovative product candidates

ZYUS Life Sciences Inc. (“ZYUS”) announced today that it has entered into a definitive agreement to acquire the Kentucky-based healthcare technology company Revon Systems, Inc. (“Revon”) in a share for share transaction. The closing date contemplated in the definitive agreement is July 31, 2019 or such other date as may be mutually agreed to between the parties, subject to the terms and conditions of the definitive agreement.

ZYUS, which is focused on the global development and commercialization of innovative and patient-focused cannabinoid-based therapeutics and product candidates, intends to utilize Revon’s proprietary technology platform as a digital therapeutic patient interface and a real-time data collection platform during various future planned clinical studies and trials.

Read the full media release.

About ZYUS

ZYUS is a Canadian-based life sciences company dedicated to restoring health and well-being. Through advocacy, research, and innovative product and service offerings, they enable healthcare professionals to leverage the power of cannabinoids to manage disease and improve patient quality of life.

For more information, visit the website.

- July 4, 2019